Connor, Clark & Lunn Investment Management Ltd. - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q2 2023$828,374
+48.0%
7,056
+0.9%
0.00%
+33.3%
Q1 2023$559,619
-57.4%
6,990
-57.9%
0.00%
-62.5%
Q4 2022$1,314,339
-23.0%
16,591
-32.2%
0.01%
-27.3%
Q3 2022$1,706,000
+712.4%
24,480
+664.5%
0.01%
+1000.0%
Q2 2022$210,000
-73.6%
3,202
-71.8%
0.00%
-75.0%
Q4 2021$795,00011,3710.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$68,951,0005.53%
S Squared Technology, LLC 85,215$6,565,0003.10%
First Light Asset Management, LLC 491,511$37,866,0002.51%
Soleus Capital Management, L.P. 166,844$12,854,0002.32%
Redmile Group, LLC 2,060,132$158,713,0002.24%
Nicholas Investment Partners, LP 304,689$23,473,0001.64%
HighMark Wealth Management LLC 17,192$1,324,0001.06%
DSAM Partners (London) Ltd 70,274$5,414,0001.00%
Artal Group S.A. 500,000$38,520,0000.68%
Hood River Capital Management LLC 237,882$18,326,0000.59%
View complete list of KRYSTAL BIOTECH INC shareholders